Capital Markets Trading (UK)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-164,291
| Closed | -$5.47M | – | 380 |
|
|
2026
Q1 | $4.95M | Buy |
164,291
+104,690
| +176% | +$3.37M | 0.06% | 153 |
|
|
2025
Q4 | $1.86M | Sell |
59,601
-40,297
| -40% | -$993K | 0.03% | 212 |
|
|
2025
Q3 | $2.02M | Sell |
99,898
-136,318
| -58% | -$2.39M | 0.03% | 206 |
|
|
2025
Q2 | $3.96M | Buy |
236,216
+189,245
| +403% | +$3.05M | 0.07% | 167 |
|
|
2025
Q1 | $722K | Sell |
46,971
-457,001
| -91% | -$8.16M | 0.01% | 244 |
|
|
2024
Q4 | $11.1M | Buy |
503,972
+137,298
| +37% | +$2.5M | 0.17% | 118 |
|
|
2024
Q3 | $6.61M | Sell |
366,674
-80,735
| -18% | -$1.41M | 0.09% | 148 |
|
|
2024
Q2 | $7.27M | Buy |
447,409
+328,159
| +275% | +$5.05M | 0.11% | 135 |
|
|
2024
Q1 | $1.68M | Buy |
119,250
+18,402
| +18% | +$232K | 0.02% | 208 |
|
|
2023
Q4 | $1.05M | Sell |
100,848
-33,767
| -25% | -$315K | 0.01% | 218 |
|
|
2023
Q3 | $1.37M | Buy |
+134,615
| New | +$1.25M | 0.02% | 217 |
|
|
2023
Q1 | – | Sell |
-258,241
| Closed | -$2.55M | – | 281 |
|
|
2022
Q4 | $2.35M | Sell |
258,241
-506,623
| -66% | -$4.42M | 0.05% | 137 |
|
|
2022
Q3 | $6.17M | Buy |
764,864
+683,013
| +834% | +$6.04M | 0.13% | 101 |
|
|
2022
Q2 | $616K | Sell |
81,851
-63,395
| -44% | -$552K | 0.01% | 185 |
|
|
2022
Q1 | $1.36M | Sell |
145,246
-1,003,223
| -87% | -$8.37M | 0.02% | 169 |
|
|
2021
Q4 | $9.2M | Buy |
1,148,469
+412,137
| +56% | +$3.72M | 0.12% | 85 |
|
|
2021
Q3 | $7.34M | Sell |
736,332
-32,797
| -4% | -$307K | 0.1% | 98 |
|
|
2021
Q2 | $7.61M | Buy |
769,129
+509,589
| +196% | +$5.39M | 0.12% | 91 |
|
|
2021
Q1 | $3M | Buy |
259,540
+69,836
| +37% | +$801K | 0.05% | 129 |
|
|
2020
Q4 | $1.83M | Sell |
189,704
-115,282
| -38% | -$1.1M | 0.02% | 138 |
|
|
2020
Q3 | $2.83M | Buy |
304,986
+233,051
| +324% | +$2.47M | 0.04% | 122 |
|
|
2020
Q2 | $887K | Buy |
+71,935
| New | +$814K | 0.02% | 148 |
|
|
2019
Q4 | – | Sell |
-95,563
| Closed | -$853K | – | 205 |
|
|
2019
Q3 | $657K | Sell |
95,563
-46,780
| -33% | -$358K | 0.03% | 170 |
|
|
2019
Q2 | $1.31M | Buy |
142,343
+117,656
| +477% | +$1.42M | 0.06% | 149 |
|
|
2019
Q1 | $387K | Buy |
24,687
+5,651
| +30% | +$99.7K | 0.02% | 159 |
|
|
2018
Q4 | $294K | Sell |
19,036
-6,336
| -25% | -$130K | 0.02% | 172 |
|
|
2018
Q3 | $547K | Buy |
25,372
+7,320
| +41% | +$170K | 0.03% | 160 |
|
|
2018
Q2 | $439K | Buy |
+18,052
| New | +$368K | 0.02% | 165 |
|
|
2018
Q1 | – | Sell |
-10,949
| Closed | -$214K | – | 183 |
|
|
2017
Q4 | $207K | Buy |
+10,949
| New | +$165K | 0.01% | 158 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Capital Markets Trading (UK)'s TEVA Position: Q2 2026 in Review
Capital Markets Trading (UK) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 164,291 shares — an estimated $5.47M sold.
Capital Markets Trading (UK) first reported a position in TEVA in Q4 2017 and held it in 29 quarters. The position peaked at $11.1M in Q4 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Capital Markets Trading (UK) reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
- Capital Markets Trading (UK) sold 164,291 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $5.47M.
- Capital Markets Trading (UK) first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and held it in 29 quarters.
- Capital Markets Trading (UK)'s Teva Pharmaceutical Industries Limited position peaked at $11.1M in Q4 2024.
- 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.
Based on Capital Markets Trading (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.